全文获取类型
收费全文 | 3172303篇 |
免费 | 297580篇 |
国内免费 | 40351篇 |
专业分类
耳鼻咽喉 | 41663篇 |
儿科学 | 91196篇 |
妇产科学 | 74559篇 |
基础医学 | 506600篇 |
口腔科学 | 82967篇 |
临床医学 | 302181篇 |
内科学 | 537145篇 |
皮肤病学 | 86495篇 |
神经病学 | 264781篇 |
特种医学 | 122279篇 |
外国民族医学 | 333篇 |
外科学 | 479179篇 |
综合类 | 157145篇 |
现状与发展 | 108篇 |
一般理论 | 2095篇 |
预防医学 | 255092篇 |
眼科学 | 74727篇 |
药学 | 234211篇 |
453篇 | |
中国医学 | 34241篇 |
肿瘤学 | 162784篇 |
出版年
2022年 | 36296篇 |
2021年 | 71743篇 |
2020年 | 50575篇 |
2019年 | 73018篇 |
2018年 | 83996篇 |
2017年 | 67951篇 |
2016年 | 72461篇 |
2015年 | 92864篇 |
2014年 | 130562篇 |
2013年 | 193594篇 |
2012年 | 102161篇 |
2011年 | 101622篇 |
2010年 | 134089篇 |
2009年 | 134901篇 |
2008年 | 78324篇 |
2007年 | 77512篇 |
2006年 | 88181篇 |
2005年 | 82720篇 |
2004年 | 78244篇 |
2003年 | 69043篇 |
2002年 | 57273篇 |
2001年 | 86742篇 |
2000年 | 78431篇 |
1999年 | 83068篇 |
1998年 | 66638篇 |
1997年 | 64768篇 |
1996年 | 61200篇 |
1995年 | 56559篇 |
1994年 | 50187篇 |
1993年 | 46402篇 |
1992年 | 51715篇 |
1991年 | 47999篇 |
1990年 | 44535篇 |
1989年 | 44811篇 |
1988年 | 41256篇 |
1987年 | 39953篇 |
1986年 | 37544篇 |
1985年 | 38107篇 |
1984年 | 37399篇 |
1983年 | 35024篇 |
1982年 | 37712篇 |
1981年 | 35824篇 |
1980年 | 33781篇 |
1979年 | 28267篇 |
1978年 | 27484篇 |
1977年 | 26231篇 |
1976年 | 23308篇 |
1975年 | 21306篇 |
1974年 | 20262篇 |
1973年 | 19306篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
942.
Stefaniuk Catherine M. Schlegelmilch June Meyerson Howard J. Harding Clifford V. Maitta Robert W. 《Journal of thrombosis and thrombolysis》2022,53(4):950-953
Journal of Thrombosis and Thrombolysis - Over the last few years data from our group have indicated that α-synuclein is important in development of immune cells as well as potentially... 相似文献
943.
944.
Calculus bovis is commonly used for the treatment of stroke in traditional Chinese medicine. Hyodeoxycholic acid(HDCA) is a bioactive compound extracted from calculus bovis. When combined with cholic acid, baicalin and jas-minoidin, HDCA prevents hypoxia-reoxygenation-induced brain injury by suppressing endoplasmic reticulum stress-mediated apoptotic signaling. However, the effects of HDCA in ischemic stroke injury have not yet been studied. Neurovascular unit(NVU) dysfunction occurs in ischemic stroke. Therefore, in this study, we investigated the effects of HDCA on the NVU under ischemic conditions in vitro. We co-cultured primary brain microvascular endothelial cells, neurons and astrocytes using a transwell chamber co-culture system. The NVU was pre-treated with 10.16 or 2.54 μg/mL HDCA for 24 hours before exposure to oxygen-glucose deprivation for 1 hour. The cell counting kit-8 assay was used to detect cell activity. Flow cytometry and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling were used to assess apoptosis. Enzyme-linked immunosorbent assay was used to measure the expression levels of inflammatory cytokines, including interleukin-1β, interleukin-6 and tumor necrosis factor-α, and neurotrophic factors, including brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. Oxidative stress-related factors, such as superoxide dismutase, nitric oxide, malondialdehyde and γ-glutamyltransferase, were measured using kits. Pretreatment with HDCA significantly decreased blood-brain barrier permeability and neuronal apoptosis, significantly increased transendothelial electrical resistance and γ-glutamyltransferase activity, attenuated oxidative stress damage and the release of inflammatory cytokines, and increased brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression. Our findings suggest that HDCA maintains NVU morphological integrity and function by modulating inflammation, oxidation stress, apoptosis, and the expression of neurotrophic factors. Therefore, HDCA may have therapeutic potential in the clinical management of ischemic stroke. This study was approved by the Ethics Committee of Experimental Animals of Beijing University of Chinese Medicine(approval No. BUCM-3-2016040201-2003) in April 2016. 相似文献
945.
946.
947.
948.
Background
Total knee arthroplasty is a treatment option for debilitating arthritis. In the postoperative period, patients experience moderate to severe pain affecting the rehabilitation, hospital stay, and patient satisfaction. This study aims at utilizing current best evidence to determine whether adductor canal block (ACB) or periarticular injection (PAI) is a better modality for managing short-term postoperative pain and opioid consumption.Methods
Embase, MEDLINE, HealthStar, Emcare, and PubMed were searched for randomized controlled trials from 1946 to August 2018, for literature addressing the comparison of ACB and PAI for pain management in the setting of total knee arthroplasty. A systematic review and meta-analysis were performed.Results
Six studies were included in our meta-analysis. When examining the combined visual analog scale (VAS) pain values for each group, analysis demonstrated greater reduction in scores for the PAI group, and the difference was statistically significant (P = .001). When comparing the VAS scores of subgroups analyzed at specific periods in time, there was a trend toward lower VAS scores in subgroups analyzed at 24 hours and 48 hours postoperatively (at rest and at movement) in the PAI group. Overall opioid consumption was lower in the PAI group, with demonstrated statistical significance (P = .03). When comparing the postoperative subgroups, there was a trend toward decreased opioid use in the PAI group, with 13.25% less opioid use at 48 hours and 9.5% less opioid use at 24 hours.Conclusion
PAI could significantly improve postoperative pain and opioid consumption when compared with ACB. Additional, high-quality studies are required to further address this topic. 相似文献949.
950.
Stefan Scholz Florian Koerber Kinga Meszaros Rosa Maya Fassbender Bernhard Ultsch Robert R. Welte Wolfgang Greiner 《Vaccine》2019,37(12):1692-1701